CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 217 filers reported holding CLOVIS ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $15,000 | -42.3% | 12,535 | -13.4% | 0.00% | – |
| Q2 2022 | $26,000 | -60.6% | 14,476 | -55.8% | 0.00% | – |
| Q1 2022 | $66,000 | -57.7% | 32,732 | -43.2% | 0.00% | -100.0% |
| Q4 2021 | $156,000 | -53.6% | 57,600 | +15.4% | 0.00% | -50.0% |
| Q2 2020 | $336,000 | -55.8% | 49,894 | -74.2% | 0.00% | -33.3% |
| Q3 2019 | $760,000 | -69.9% | 193,388 | +14.1% | 0.00% | -66.7% |
| Q2 2019 | $2,521,000 | -39.4% | 169,524 | +1.2% | 0.01% | -43.8% |
| Q1 2019 | $4,158,000 | -29.2% | 167,524 | -48.8% | 0.02% | -38.5% |
| Q4 2018 | $5,877,000 | +126.0% | 327,270 | +269.5% | 0.03% | +188.9% |
| Q3 2018 | $2,601,000 | -63.8% | 88,573 | -43.9% | 0.01% | -70.0% |
| Q2 2018 | $7,183,000 | – | 157,968 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 407,416 | $14,259,560,000 | 8.34% |
| Palo Alto Investors LP | 3,547,719 | $124,170,000 | 6.91% |
| Antipodean Advisors LLC | 1,268,658 | $44,403,000 | 6.48% |
| Redmile Group, LLC | 1,795,936 | $62,858,000 | 4.70% |
| HealthCor Management, L.P. | 1,525,000 | $53,375,000 | 3.24% |
| PointState Capital LP | 3,503,900 | $122,637,000 | 3.12% |
| NEA Management Company, LLC | 1,139,890 | $39,896,000 | 2.54% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 612,500 | $21,438,000 | 2.44% |
| PFM Health Sciences, LP | 2,078,440 | $72,745,000 | 2.21% |
| Partner Investment Management, L.P. | 35,300 | $1,236,000 | 2.03% |